Clarus Therapeutics Holdings, Inc. Income Statement | Understand Stock

Login

Understand Stock

Sign in or create a free account to unlock 10 years of data, build your watchlist, create alerts and more.

Sign in

$0.00 +$0.00 (0.0%)

Deep Research with AI Research

Overview

Overview Financials SEC Filings Executives News

Specialized Tools

Valuations P Insider Transactions P Congressional Trades P

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Income Statement

Concept	2021	2020	2019
Revenue	$13.96M 119.14% YoY	$6.369M N/A	$0.00 N/A
Cost Of Revenue	$2.720M -68.69% YoY	$8.687M N/A	$0.00 N/A
Gross Profit	$11.24M -584.77% YoY	-$2.318M N/A	$0.00 N/A
Selling, General & Admin	$47.34M 14.2% YoY	$41.45M 180.31% YoY	$14.79M N/A
Research & Development	$3.630M 6.55% YoY	$3.407M 10.33% YoY	$3.088M N/A
Depreciation & Amortization	$25.00K 38.89% YoY	$18.00K 350.0% YoY	$4.000K N/A
Operating Expenses	$50.97M 13.62% YoY	$44.86M 150.95% YoY	$17.88M N/A
Operating Profit	-$39.73M -15.78% YoY	-$47.18M 163.91% YoY	-$17.88M N/A
Interest Expense	-$15.89M 3.41% YoY	-$15.37M -35.39% YoY	-$23.79M N/A
Other Income/Expense, Net	$12.51M -81.3% YoY	$66.89M 514446.15% YoY	$13.00K N/A
Pretax Income	-$40.62M -1034.8% YoY	$4.345M -110.43% YoY	-$41.65M N/A
Income Tax	$0.00 N/A	$0.00 N/A	$0.00 N/A
Net Earnings	-$40.62M -1034.8% YoY	$4.345M -110.43% YoY	-$41.65M N/A
Basic Earnings Per Share	N/A	N/A	N/A
Diluted Earnings Per Share	-$1.691M -945.31% YoY	$200.0K -110.43% YoY	-$1.917M N/A
COMMON SHARES	N/A	N/A	N/A
Basic Shares Outstanding	N/A	N/A	N/A
Diluted Shares Outstanding	N/A	N/A	N/A

Concept	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2020 Q4
Revenue	$4.050M 45.74% YoY	$4.011M 72.15% YoY	$4.562M 88.05% YoY	$4.286M 92.72% YoY	$2.779M N/A	$2.426M N/A
Cost Of Revenue	$1.160M 109.39% YoY	$664.0K 80.93% YoY	$1.289M 259.05% YoY	$510.0K 98.44% YoY	$554.0K N/A	$359.0K N/A
Gross Profit	$2.890M 29.89% YoY	$3.347M 70.5% YoY	$3.273M 58.35% YoY	$3.776M 91.97% YoY	$2.225M N/A	$2.067M N/A
Selling, General & Admin	$12.31M -53.36% YoY	$16.01M 38.75% YoY	$10.01M 3.86% YoY	$10.93M -7.13% YoY	$26.40M 3473452.63% YoY	$9.634M N/A
Research & Development	$1.229M 102.81% YoY	$881.0K -27.25% YoY	$537.0K N/A	$1.275M -11.27% YoY	$606.0K N/A	N/A
Depreciation & Amortization	N/A	$7.000K N/A	$7.000K 75.0% YoY	$6.000K -57.14% YoY	$12.00K N/A	$4.000K N/A
Operating Expenses	$13.54M -12.42% YoY	$16.90M 32.48% YoY	$10.54M 3.13% YoY	$12.21M -7.58% YoY	$15.46M 2034505.26% YoY	$10.22M N/A
Operating Profit	-$10.65M -19.53% YoY	-$13.55M 25.56% YoY	-$7.270M -10.86% YoY	-$8.433M -24.99% YoY	-$13.24M N/A	-$8.156M N/A
Interest Expense	$2.020M -58.58% YoY	-$1.964M -57.67% YoY	-$1.930M -58.07% YoY	-$4.446M 3.64% YoY	$4.877M N/A	-$4.603M N/A
Other Income/Expense, Net	-$42.00K -99.14% YoY	$642.0K N/A	$4.898M -62.43% YoY	$7.610M -63.66% YoY	-$4.877M N/A	$13.04M N/A
Pretax Income	-$10.69M -40.97% YoY	-$14.87M -3.63% YoY	-$4.302M -1647.48% YoY	-$2.769M -151.22% YoY	-$18.12M 2383452.63% YoY	$278.0K N/A
Income Tax	N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A	$0.00 N/A
Net Earnings	-$10.69M -40.97% YoY	-$14.87M -3.62% YoY	-$4.302M -1647.48% YoY	-$2.769M -151.22% YoY	-$18.12M 2383452.63% YoY	$278.0K N/A
Basic Earnings Per Share	-$0.24 N/A	N/A	N/A	N/A	$0.00 N/A	N/A
Diluted Earnings Per Share	-$0.24 N/A	-$614.4K -13.49% YoY	-$139.1K -1187.13% YoY	-$127.5K -151.22% YoY	$0.00 -100.0% YoY	$12.80K N/A
COMMON SHARES	N/A	N/A	N/A	N/A	N/A	N/A
Basic Shares Outstanding	44.23M N/A	N/A	N/A	N/A	0.000 N/A	N/A
Diluted Shares Outstanding	44.23M N/A	N/A	N/A	N/A	0.000 N/A	N/A

Loading...